Insulin Lispro-Aabc has 37 known drug interactions based on U.S. FDA drug labeling data. Notable interactions include combinations with Albuterol, Alcohol, Angiotensin Ii. Patients taking Insulin Lispro-Aabc should inform their healthcare provider of all current medications — including over-the-counter drugs and supplements — to avoid potentially harmful combinations. Data sourced from OpenFDA and the NIH National Library of Medicine.
- Total
- 37
- Moderate
- 35
Moderate (35)
- Insulin Lispro-Aabc + Albuterol— Sympathomimetic agent that may decrease blood glucose lowering effect. Dose increases and increased glucose monitoring m…
- Insulin Lispro-Aabc + Alcohol— May increase or decrease blood glucose lowering effect. Dose adjustment and increased glucose monitoring may be required…
- Insulin Lispro-Aabc + Angiotensin Ii— May increase risk of hypoglycemia. Dose reductions and increased glucose monitoring may be required.
- Insulin Lispro-Aabc + Clonidine— May increase or decrease blood glucose lowering effect and blunt signs/symptoms of hypoglycemia. Dose adjustment and inc…
- Insulin Lispro-Aabc + Clozapine— Atypical antipsychotic that may decrease blood glucose lowering effect. Dose increases and increased glucose monitoring …
- Insulin Lispro-Aabc + Corticosteroids— May decrease blood glucose lowering effect. Dose increases and increased glucose monitoring may be required.
- Insulin Lispro-Aabc + Danazol— May decrease blood glucose lowering effect. Dose increases and increased glucose monitoring may be required.
- Insulin Lispro-Aabc + Disopyramide— May increase risk of hypoglycemia. Dose reductions and increased glucose monitoring may be required.
- Insulin Lispro-Aabc + Diuretics— May decrease blood glucose lowering effect. Dose increases and increased glucose monitoring may be required.
- Insulin Lispro-Aabc + Epinephrine— Sympathomimetic agent that may decrease blood glucose lowering effect. Dose increases and increased glucose monitoring m…
- Insulin Lispro-Aabc + Estrogens— May decrease blood glucose lowering effect. Dose increases and increased glucose monitoring may be required.
- Insulin Lispro-Aabc + Fibrates— May increase risk of hypoglycemia. Dose reductions and increased glucose monitoring may be required.
- Insulin Lispro-Aabc + Fluoxetine— May increase risk of hypoglycemia. Dose reductions and increased glucose monitoring may be required.
- Insulin Lispro-Aabc + Glucagon— May decrease blood glucose lowering effect. Dose increases and increased glucose monitoring may be required.
- Insulin Lispro-Aabc + Guanethidine— May blunt signs and symptoms of hypoglycemia. Increased frequency of glucose monitoring may be required.
- Insulin Lispro-Aabc + Isoniazid— May decrease blood glucose lowering effect. Dose increases and increased glucose monitoring may be required.
- Insulin Lispro-Aabc + Lithium— May increase or decrease blood glucose lowering effect. Dose adjustment and increased glucose monitoring may be required…
- Insulin Lispro-Aabc + Macrolide Antibiotics— May increase risk of hypoglycemia. Dose reductions and increased glucose monitoring may be required.
- Insulin Lispro-Aabc + Mao Inhibitors— May increase risk of hypoglycemia. Dose reductions and increased glucose monitoring may be required.
- Insulin Lispro-Aabc + Monoamine Oxidase Inhibitors (Maois)— May increase risk of hypoglycemia. Dose reductions and increased glucose monitoring may be required.
- Insulin Lispro-Aabc + Niacin— May decrease blood glucose lowering effect. Dose increases and increased glucose monitoring may be required.
- Insulin Lispro-Aabc + Nonselective Beta-Adrenergic Antagonists— May increase or decrease blood glucose lowering effect and blunt signs/symptoms of hypoglycemia. Dose adjustment and inc…
- Insulin Lispro-Aabc + Octreotide— Somatostatin analog that may increase risk of hypoglycemia. Dose reductions and increased glucose monitoring may be requ…
- Insulin Lispro-Aabc + Olanzapine— Atypical antipsychotic that may decrease blood glucose lowering effect. Dose increases and increased glucose monitoring …
- Insulin Lispro-Aabc + Oral Contraceptives— May decrease blood glucose lowering effect. Dose increases and increased glucose monitoring may be required.
- Insulin Lispro-Aabc + Pentamidine— May cause hypoglycemia sometimes followed by hyperglycemia. Dose adjustment and increased glucose monitoring may be requ…
- Insulin Lispro-Aabc + Pentoxifylline— May increase risk of hypoglycemia. Dose reductions and increased glucose monitoring may be required.
- Insulin Lispro-Aabc + Phenothiazines— May decrease blood glucose lowering effect. Dose increases and increased glucose monitoring may be required.
- Insulin Lispro-Aabc + Pramlintide— May increase risk of hypoglycemia. Dose reductions and increased glucose monitoring may be required.
- Insulin Lispro-Aabc + Protease Inhibitors— May decrease blood glucose lowering effect. Dose increases and increased glucose monitoring may be required.
- Insulin Lispro-Aabc + Reserpine— May blunt signs and symptoms of hypoglycemia. Increased frequency of glucose monitoring may be required.
- Insulin Lispro-Aabc + Salicylates— May increase risk of hypoglycemia. Dose reductions and increased glucose monitoring may be required.
- Insulin Lispro-Aabc + Somatropin— May decrease blood glucose lowering effect. Dose increases and increased glucose monitoring may be required.
- Insulin Lispro-Aabc + Terbutaline— Sympathomimetic agent that may decrease blood glucose lowering effect. Dose increases and increased glucose monitoring m…
- Insulin Lispro-Aabc + Thyroid Hormones— May decrease blood glucose lowering effect. Dose increases and increased glucose monitoring may be required.